Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma

Author：  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.28, Iss.3, 2012-01, pp. : 1051-1056

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix metalloproteinase2 and 9 and tissue inhibitor of metalloproteinase1 and 2 in sera and urine of patients with renal carcinoma

By  

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 621-626

Spandidos Publications

Access to resources Recommend Favorite

The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma

By Lu Hongsheng   Yang Zhaohui   Zhang Hui   Gan Meifu   Zhou Tao   Wang Siling  

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-03 ,pp. : 890-896

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase9 (MMP9) and their complex MMP9/NGAL in sera and urine of patients with kidney tumors

By  

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1677-1681

Spandidos Publications

Access to resources Recommend Favorite

Expression levels of matrix metalloproteinase-9 in human gastric carcinoma

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 915-919

Spandidos Publications

Access to resources Recommend Favorite

Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma

By                

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3585-3592

Spandidos Publications

Access to resources Recommend Favorite